Comera Life Sciences

Comera Life Sciences is a formulation innovator in the field of protein therapeutics, striving to transform the formulation of biotherapeutics for the ultimate benefit of patients. The company's proprietary technology offers patented, FDA-friendly excipients catering to a wide range of therapeutic biologics, making life-saving medicines easier to administer, less immunogenic, more stable, and efficient to produce. Through their efforts to enhance therapeutic protein formulations, Comera aims to turn biologic molecules into biobetters, thereby improving the overall patient experience and potentially extending a product’s lifecycle. Founded in 2014 by prolific entrepreneur David Soane, the company is driven by a team of experienced scientists who are committed to advancing their technology. Recent investment of $4.10M in Post-IPO Equity was made on 01 August 2023. Comera Life Sciences operates at the intersection of Biotechnology, Health Care, and Health and Wellness.